Skip to main content
. 2022 Jan 7;17(1):135–150. doi: 10.1515/med-2021-0405

Figure 6.

Figure 6

KM curve analysis of 4-mRNA signature in clinical features: (a) prognostic KM curve in elderly samples (age >60), (b) prognostic KM curve in young samples (age ≤60), (c) prognostic KM curve in serum AFP greater than 300 samples, (d) prognostic KM curve in serum AFP <300 samples, (e) prognostic KM curve in the male sample, (f) prognostic KM curve in the female sample, (g) prognostic KM curve in Caucasian samples, (h) prognostic KM curve in Asian samples, (i) prognostic KM curve in Stage I + Phase II samples, (j) prognostic KM curve in Stage III samples, (k) prognostic KM curve in Grade I + II samples, and (l) prognostic KM curve in Grade III samples.